C09DA07 • telmisartan + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics
This combination of telmisartan and hydrochlorothiazide is used for the treatment of hypertension in patients not adequately controlled with a single medication. Telmisartan blocks angiotensin II receptors, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
Substance: telmisartan + hydrochlorothiazide
Date of last drug list: 01-01-2014
Commercial code: W60098001
Concentration: 80mg / 12.5mg
Pharmaceutical form: dragees
Quantity: 28
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.